ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.96
0.71%
US Tech 100
20,762.73
1.73%
S&P 500
5,942.47
1.26%
US Dollar vs CAD
1.44457
0.00%
Bitcoin
97,671.86
-0.55%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Lacroix Group (LACR) Share Price

Lacroix Group

Lacroix Group (LACR)

EU
9.38
-0.12
(-1.26%)
Closed January 05 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
9.38
Bid
9.34
Ask
9.48
Volume
3,953
9.38 Day's Range 9.70
8.46 52 Week Range 31.50
Market Cap
43.91M
Previous Close
9.50
Open
9.70
Last Trade
80
@
9.38
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,273
Shares Outstanding
4,681,203
Dividend Yield
7.46%
PE Ratio
10.29
Earnings Per Share (EPS)
0.91
Revenue
764.76M
Net Profit
4.27M

About Lacroix Group

Sector
Indl, Coml Machy, Equip, Nec
Industry
Elec Meas & Test Instruments
Website
www.lacroix-group.com
Headquarters
Saint-herblain, Loire-atlantique, Fra
Founded
1993
Lacroix Group is listed in the Indl, Coml Machy, Equip sector of the Euronext with ticker LACR. The last closing price for Lacroix was 9.50 €. Over the last year, Lacroix shares have traded in a share price range of 8.46 € to 31.50 €.

Lacroix currently has 4,681,203 shares outstanding. The market capitalization of Lacroix is 44.47 € million. Lacroix has a price to earnings ratio (PE ratio) of 10.29.

Ask ADVFN Intelligence (AI)

LACR Latest News

More News

LACROIX in exclusive negotiations with the SWARCO group for the divestment of its City-Mobility segment.

LACROIX in exclusive negotiations with the SWARCO group for the divestment of its City-Mobility segment. LACROIX in exclusive negotiations with the SWARCO group for the divestment of its...

December 12 2024
UK Regulatory

LACROIX entre en négociations exclusives avec le groupe SWARCO en vue de la cession de son segment City-Mobilité.

LACROIX entre en négociations exclusives avec le groupe SWARCO en vue de la cession de son segment City-Mobilité. LACROIX entre en négociations exclusives avec le groupe SWARCO en vue de la...

December 12 2024
UK Regulatory

LACROIX : In a persistently buoyant market, the activity Environment of LACROIX successfully revitalizes its offer in all segments.

LACROIX : In a persistently buoyant market, the activity Environment of LACROIX successfully revitalizes its offer in all segments. In a persistently buoyant market, the activity Environment of...

November 25 2024
UK Regulatory

LACROIX : Sur un marché durablement porteur, l’activité Environment de LACROIX renouvelle avec succès son offre sur tous ses segments.

LACROIX : Sur un marché durablement porteur, l’activité Environment de LACROIX renouvelle avec succès son offre sur tous ses segments. Sur un marché durablement porteur, l’activité Environment de...

November 25 2024
UK Regulatory

LACROIX : Le chiffre d’affaires consolidé ressort à 494,2 M€ sur les 9 premiers mois de l’exercice 2024, en repli de 6,3% à périmètre constant.

LACROIX : Le chiffre d’affaires consolidé ressort à 494,2 M€ sur les 9 premiers mois de l’exercice 2024, en repli de 6,3% à périmètre constant. Le chiffre d’affaires consolidé ressort à 494,2 M€...

November 07 2024
UK Regulatory

LACROIX : Consolidated revenue of €494,2 million for the first 9 months of FY 2024, down 6.3% on a like-for-like basis.

LACROIX : Consolidated revenue of €494,2 million for the first 9 months of FY 2024, down 6.3% on a like-for-like basis. Consolidated revenue of €494,2 million for the first 9 months of FY 2024...

November 07 2024
UK Regulatory

LACROIX : Premier semestre 2024 : Chiffre d’affaires 2024 de 350,3 M€, en repli de 4,9% à périmètre constant. Progression de la rentabilité opérationnelle courante, hors Amérique du Nord.

LACROIX : Premier semestre 2024 : Chiffre d’affaires 2024 de 350,3 M€, en repli de 4,9% à périmètre constant. Progression de la rentabilité opérationnelle courante, hors Amérique du Nord...

September 30 2024
UK Regulatory

LACROIX : First-half 2024: €350.3m revenue, down 4.9% on a like-for-like basis. Increase in current operating profitability, excl. North America.

LACROIX : First-half 2024: €350.3m revenue, down 4.9% on a like-for-like basis. Increase in current operating profitability, excl. North America. 30/09/2024 First-half 2024: €350.3m revenue, down...

September 30 2024
UK Regulatory

LACROIX : After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows solid growth.

LACROIX : After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows solid growth. After two years in operation, LACROIX’s Symbiose plant in Beaupréau-en-Mauges shows...

September 16 2024
UK Regulatory

LACROIX : Deux ans après son ouverture, l’usine Symbiose de LACROIX à Beaupréau-en-Mauges affiche une croissance solide.

LACROIX : Deux ans après son ouverture, l’usine Symbiose de LACROIX à Beaupréau-en-Mauges affiche une croissance solide. Deux ans après son ouverture, l’usine Symbiose de LACROIX à...

September 16 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.080.8602150537639.39.729.2632769.48899878DE
4-0.34-3.497942386839.7210.78.4682409.45810272DE
12-4.72-33.47517730514.114.38.46427310.36591425DE
26-10.92-53.793103448320.322.38.46300713.31274078DE
52-21.02-69.144736842130.431.58.46230017.54296335DE
156-33.92-78.33718244843.346.58.46221126.92564537DE
260-18.82-66.737588652528.2538.46190828.91133318DE

LACR - Frequently Asked Questions (FAQ)

What is the current Lacroix share price?
The current share price of Lacroix is 9.38 €
How many Lacroix shares are in issue?
Lacroix has 4,681,203 shares in issue
What is the market cap of Lacroix?
The market capitalisation of Lacroix is EUR 44.47M
What is the 1 year trading range for Lacroix share price?
Lacroix has traded in the range of 8.46 € to 31.50 € during the past year
What is the PE ratio of Lacroix?
The price to earnings ratio of Lacroix is 10.29
What is the cash to sales ratio of Lacroix?
The cash to sales ratio of Lacroix is 0.06
What is the reporting currency for Lacroix?
Lacroix reports financial results in EUR
What is the latest annual turnover for Lacroix?
The latest annual turnover of Lacroix is EUR 764.76M
What is the latest annual profit for Lacroix?
The latest annual profit of Lacroix is EUR 4.27M
What is the registered address of Lacroix?
The registered address for Lacroix is 17 RUE OCEANE, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
What is the Lacroix website address?
The website address for Lacroix is www.lacroix-group.com
Which industry sector does Lacroix operate in?
Lacroix operates in the ELEC MEAS & TEST INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M

Discussion

View Full Feed
sylvia07 sylvia07 16 minutes ago
Not only synthetic shares but according to this website, dbmm has short shares.
https://www.otcshortreport.com/company/DBMM
DBMM
Seminole Red Seminole Red 19 minutes ago
https://scontent-mia3-3.xx.fbcdn.net/v/t39.30808-6/472293302_905802825095374_3473832870245612767_n.jpg?_nc_cat=108&ccb=1-7&_nc_sid=0b6b33&_nc_ohc=YJtCmvz6wwMQ7kNvgHWh25c&_nc_zt=23&_nc_ht=scontent-mia3-3.xx&_nc_gid=Ae15H9ngLafLkQISdO6zu87&oh=00_AYA5xkIONTr9ECCR2EwlP9fecienD49rx9m8zqvpxYE8yA&oe=678013
Peter J Peter J 21 minutes ago
He will go on and on forever saying the same old tired lines.
Now you are speaking to yourself again, right?

I'ts all to the UTMOST importance for you "I have no financial interest in ERHC" guys, right?

In the States there is so much altruistic work possible, a
ERHE
SkeBallLarry SkeBallLarry 23 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 24 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 25 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
Peter J Peter J 26 minutes ago
Your problem if "altruism" is a dirty word to you
What you seem to forget... every time again, is....

Everything that is said here is all very, extremely, important to you, huh?

🤣

You postings style over the boards is SO clear, that Badog
ERHE
SkeBallLarry SkeBallLarry 26 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
befast befast 28 minutes ago
Positive for a change. The fact that the stock has been able to crawl back to pre RS level of 5.602 is a bullish sign. Let's see if it can stay above it next week. Nevertheless we are still trading way below 12, which was already a depressed presplit level
XXII
Nezitic Nezitic 29 minutes ago
I'm not really surprised if it goes back to 1.3 where it was. Lot of manipulation and dilution with this one...probably they will send this to $1 by purpose to pump it again until buying pressure stops and then back again under $1.
HOLO
Termite7 Termite7 36 minutes ago
7 trades is unheard of!!!!
PHMB
FranCoRazon FranCoRazon 37 minutes ago
This message of yours shows how wrong, manupulative and incomplete you were and are.

-what Lebby said has no value anymore? Lol. He was and is part of an industry that will come to fruition soon.
-lebby was fired? We still don’t know how things were settled.
-and
LWLG
toohot toohot 43 minutes ago
I will be so glad when BIEL gets out of the trips and gets rid of all the RIF RAF.
‘Nuff said?




BUY $BIEL$
BIEL
Seminole Red Seminole Red 53 minutes ago
super bowl will roll on as programed
Seminole Red Seminole Red 53 minutes ago
penn state looking strong too
CanItBThisEZ2Make CanItBThisEZ2Make 55 minutes ago
BEST SELLERS RANK (BSR) IS 756 3 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Decr
SRMX
cottonisking cottonisking 57 minutes ago
🗼🗽Category Description of tasks
Tax and VAT
Work reported in this category includes
compliance with tax legislation under
the Administrators’ obligations as proper
officers for tax, and planning to ensure
the efficient realisation of assets f
MCF
eagle8 eagle8 57 minutes ago
Tommy Bax 🇬🇧 🇹🇼
@TommyBaxendale
·
13h
Replying to
@GoneGoodguy
Further to my other tweet above, I can confirm that none of the seemingly key researchers working on the Imperial College London BioNtech mRNA cancer vaccine (Pol
NWBO
eagle8 eagle8 1 hour ago
Peter Davis
@peter_brit
#dcvax $nwbo #gbm

FDA Signals potential for standard approval of Paxalisib in Glioblastoma - AI Analysis (Gemini) of possible implications for FDA approval of #dcvax

The FDA's decision regarding paxalisib in glioblastoma (GBM) pro
NWBO
Iggy_Bot Iggy_Bot 1 hour ago
Im so happy dems are doing stuff like this, Nevada should be red for a long time now
and between the people of the state and Trump i would bet it will be over turned,
ElectricMountain53 ElectricMountain53 1 hour ago
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 2 hours ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 2 hours ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 2 hours ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL

Your Recent History

EU
LACR
Lacroix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads